We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Eurocine Vaccines

News List

Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate prnasia
December 31, 2020
Eurocine Vaccines AB has today selected Biovian Oy, Turku, Finland, as the contract developer for the Company's vaccine candidate against chlamydia. Biovian, which is an internationally recognized contract developer and manufacturer with its own GMP ...
Eurocine Vaccines Obtains Authorization to Conduct the Next Study with Immunose™ FLU prnasia
January 12, 2018
Eurocine Vaccine Corporation today announced that it has been approved to conduct phase I / II clinical studies on the immunose ™ FLU quadrivalent vaccine candidate